News
2024
April 15, 2024
Brookline Capital Markets Expands Regional Breadth and Industry Depth with Key New Hires
VIEW PRESS RELEASEApril 11, 2024
Carmell Announces Successful Closing Of $3.0 Million Private Placement
VIEW PRESS RELEASEMarch 28, 2024
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
VIEW PRESS RELEASEMarch 25, 2024
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
VIEW PRESS RELEASEFebruary 26, 2024
DT Cloud Acquisition Corporation Completes $69 Million Initial Public Offering
VIEW PRESS RELEASE2023
December 27, 2023
Media and entertainment SPAC Iron Horse Acquisitions prices upsized $61 million IPO
VIEW PRESS RELEASENovember 10, 2023
AI Transportation Acquisition Corp Announces Pricing Of $60,000,000 Initial Public Offering
VIEW PRESS RELEASEOctober 31, 2023
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
VIEW PRESS RELEASEOctober 11, 2023
Quetta Acquisition Corporation Announces Closing of $69 Million Initial Public Offering
VIEW PRESS RELEASEOctober 2, 2023
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
VIEW PRESS RELEASE2022
December 23, 2022
IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
VIEW PRESS RELEASEDecember 23, 2022
Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note
VIEW PRESS RELEASEDecember 7, 2022
X4 Pharmaceuticals Prices $65.0 Million Public Offering
VIEW PRESS RELEASEDecember 7, 2022
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
VIEW PRESS RELEASENovember 30, 2022
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
VIEW PRESS RELEASE2021
October 28, 2021
CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 25, 2021
Creatd Announces Pricing of Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
VIEW PRESS RELEASEOctober 22, 2021
Industrial Human Capital, Inc. Announces Closing of $115 Million Initial Public Offering
VIEW PRESS RELEASEOctober 8, 2021
Mount Rainier Acquisition Corp. Announces Closing of $172.5 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
VIEW PRESS RELEASESeptember 20 2021
HHG Capital Corporation Prices $50 Million Initial Public Offering
VIEW PRESS RELEASE2020
December 17, 2020
SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
VIEW PRESS RELEASEDecember 16, 2020
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market
VIEW PRESS RELEASEDecember 14, 2020
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market
VIEW PRESS RELEASEDecember 11, 2020
9 Meters Biopharma, Inc. Prices Public Offering of Common Stock
VIEW PRESS RELEASENovember 12, 2020
InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"
VIEW PRESS RELEASE2019
December 23, 2019
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
VIEW PRESS RELEASEDecember 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 22, 2019
Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
VIEW PRESS RELEASESeptember 26, 2019
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
VIEW PRESS RELEASEAugust 6, 2019
BioCardia Announces Closing of $10.0 Million Public Offering
VIEW PRESS RELEASE